158 related articles for article (PubMed ID: 28427427)
1. Association between the ossific nucleus and osteonecrosis in treating developmental dysplasia of the Hip: updated meta-analysis.
Niziol R; Elvey M; Protopapa E; Roposch A
BMC Musculoskelet Disord; 2017 Apr; 18(1):165. PubMed ID: 28427427
[TBL] [Abstract][Full Text] [Related]
2. The effect of the femoral head ossific nucleus in the treatment of developmental dysplasia of the hip. A meta-analysis.
Roposch A; Stöhr KK; Dobson M
J Bone Joint Surg Am; 2009 Apr; 91(4):911-8. PubMed ID: 19339576
[TBL] [Abstract][Full Text] [Related]
3. Presence of the Ossific Nucleus and Risk of Osteonecrosis in the Treatment of Developmental Dysplasia of the Hip: A Meta-Analysis of Cohort and Case-Control Studies.
Chen C; Doyle S; Green D; Blanco J; Scher D; Sink E; Dodwell ER
J Bone Joint Surg Am; 2017 May; 99(9):760-767. PubMed ID: 28463920
[TBL] [Abstract][Full Text] [Related]
4. Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.
Novais EN; Hill MK; Carry PM; Heyn PC
Clin Orthop Relat Res; 2016 May; 474(5):1166-77. PubMed ID: 26472583
[TBL] [Abstract][Full Text] [Related]
5. The presence of an ossific nucleus does not protect against osteonecrosis after treatment of developmental dysplasia of the hip.
Roposch A; Odeh O; Doria AS; Wedge JH
Clin Orthop Relat Res; 2011 Oct; 469(10):2838-45. PubMed ID: 21312075
[TBL] [Abstract][Full Text] [Related]
6. Reduction of a dislocation of the hip due to developmental dysplasia. Implications for the need for future surgery.
Luhmann SJ; Bassett GS; Gordon JE; Schootman M; Schoenecker PL
J Bone Joint Surg Am; 2003 Feb; 85(2):239-43. PubMed ID: 12571300
[TBL] [Abstract][Full Text] [Related]
7. The prognostic importance of the ossific nucleus in the treatment of congenital dysplasia of the hip.
Luhmann SJ; Schoenecker PL; Anderson AM; Bassett GS
J Bone Joint Surg Am; 1998 Dec; 80(12):1719-27. PubMed ID: 9875929
[TBL] [Abstract][Full Text] [Related]
8. Does Perfusion MRI After Closed Reduction of Developmental Dysplasia of the Hip Reduce the Incidence of Avascular Necrosis?
Gornitzky AL; Georgiadis AG; Seeley MA; Horn BD; Sankar WN
Clin Orthop Relat Res; 2016 May; 474(5):1153-65. PubMed ID: 26092677
[TBL] [Abstract][Full Text] [Related]
9. Avascular necrosis after treatment of DDH: the protective influence of the ossific nucleus.
Segal LS; Boal DK; Borthwick L; Clark MW; Localio AR; Schwentker EP
J Pediatr Orthop; 1999; 19(2):177-84. PubMed ID: 10088684
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Avascular Necrosis After Closed Reduction for Developmental Dysplasia of the Hip.
Bian Z; Guo Y; Lyu X; Zhu Z; Yang Z; Wang Y
J Pediatr Orthop; 2022 Oct; 42(9):467-473. PubMed ID: 35948526
[TBL] [Abstract][Full Text] [Related]
11. The surgical treatment of established congenital dislocation of the hip: results of surgery after planned delayed intervention following the appearance of the capital femoral ossific nucleus.
Clarke NM; Jowett AJ; Parker L
J Pediatr Orthop; 2005; 25(4):434-9. PubMed ID: 15958890
[TBL] [Abstract][Full Text] [Related]
12. Is the absence of the ossific nucleus prognostic for avascular necrosis after closed reduction of developmental dysplasia of the hip?
Carney BT; Clark D; Minter CL
J Surg Orthop Adv; 2004; 13(1):24-9. PubMed ID: 15055492
[TBL] [Abstract][Full Text] [Related]
13. Impact of presence of ossific nucleus on results of closed reduction in treatment of developmental dysplasia of the hip (302 hips).
Yilar S; Köse M; Tuncer K; Karsan O; Topal M; Ezirmik N
J Pediatr Orthop B; 2021 Mar; 30(2):126-131. PubMed ID: 32453121
[TBL] [Abstract][Full Text] [Related]
14. Medial versus anterior open reduction for developmental hip dislocation in age-matched patients.
Hoellwarth JS; Kim YJ; Millis MB; Kasser JR; Zurakowski D; Matheney TH
J Pediatr Orthop; 2015 Jan; 35(1):50-6. PubMed ID: 25379818
[TBL] [Abstract][Full Text] [Related]
15. Middle Term Results of Simple Open Hip Reduction of Irreducible DDH - What Is the Cut-off Age to Safely Perform It with Lower Complications?
Alexiev V; Georgiev H; Mileva S
Acta Chir Orthop Traumatol Cech; 2017; 84(5):386-390. PubMed ID: 29351541
[TBL] [Abstract][Full Text] [Related]
16. Chondronecrosis of the hip. The protective role of the ossific nucleus in an animal model.
Segal LS; Berlin JM; Schneider DJ; Moulton MJ; Frauenhoffer EE
Clin Orthop Relat Res; 2000 Aug; (377):265-71. PubMed ID: 10943210
[TBL] [Abstract][Full Text] [Related]
17. The medial approach for the treatment of children with developmental dysplasia of the hip.
Tarassoli P; Gargan MF; Atherton WG; Thomas SR
Bone Joint J; 2014 Mar; 96-B(3):406-13. PubMed ID: 24589800
[TBL] [Abstract][Full Text] [Related]
18. Early treatment with the von Rosen splint for neonatal instability of the hip is safe regarding avascular necrosis of the femoral head: 229 consecutive children observed for 6.5 years.
Wenger D; Samuelsson H; Düppe H; Tiderius CJ
Acta Orthop; 2016; 87(2):169-75. PubMed ID: 26730503
[TBL] [Abstract][Full Text] [Related]
19. Functional outcomes in children with osteonecrosis secondary to treatment of developmental dysplasia of the hip.
Roposch A; Liu LQ; Offiah AC; Wedge JH
J Bone Joint Surg Am; 2011 Dec; 93(24):e145. PubMed ID: 22258780
[TBL] [Abstract][Full Text] [Related]
20. Analysis of osteonecrosis following Pemberton acetabuloplasty in developmental dysplasia of the hip: long-term results.
Wu KW; Wang TM; Huang SC; Kuo KN; Chen CW
J Bone Joint Surg Am; 2010 Sep; 92(11):2083-94. PubMed ID: 20810858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
